Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 801

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 6
Chunk 801
---
. Although the Company cannot predict with assurance
the outcome of any litigation or tax matters, it does not believe there are currently any such actions that, if resolved unfavorably,
would have a material impact on the Company’s operating results, financial position or cash flows.

F-16

Note 9 - Stockholder’s equity/Issued capital

Common stock

The Company has one class of common stock. In connection
with the redomiciliation, the Company’s amended and restated certificate of incorporation became effective, which originally provided
for the issuance of 100 million authorized shares of common stock with a par value of $0.0001 per share, with one vote per share. Holders
of common stock are entitled to receive any dividends as may be declared from time to time by the Company’s board of directors.

On November 28, 2023, the Company effected the
redomiciliation. All references in these consolidated financial statements to the Company’s outstanding common stock, including
per share information, have been retrospectively adjusted to reflect this redomiciliation.

    For
                                            the fiscal year ended 
                                            June 30, 2024 

    $  
    No. of 
Shares 

    (in thousands,  except per share data) 
  
    Opening balance 
     2  
     15,873,113 
  
    Issues of new shares - employees and directors 
     -  
     1,769,719 
  
    Closing balance 
     2  
     17,642,832 

    For the fiscal year ended June 30, 2025 

    $  
    No. of  Shares 

    (in thousands,  except per share data) 
  
    Opening balance 
     2  
     17,642,832 
  
    Issue of new shares 
     18  
     176,049,053 
  
    Issues of new shares – convertible note conversion 
     -  
     64,127 
  
    Issues of new shares - employees and directors 
     -  
     623,984 
  
    Closing balance 
     20  
     194,379,996 

On May 27, 2025, the Company filed a certificate
amendment to its restated certificate of incorporation to increase its authorized shares of common stock to 800 million shares.

Note 10 - Additional paid-in capital

Additional paid-in